# Clinical Evaluation of the AP203 Plant Extract Mixture in Adult Patients With Increased Incidence of Viral and/or Bacterial Upper Respiratory Tract Infections

> **NCT06020001** · NA · COMPLETED · sponsor: **AronPharma Sp. z o. o.** · enrollment: 60 (actual)

## Conditions studied

- Upper Respiratory Tract Infection Bacterial

## Interventions

- **DIETARY_SUPPLEMENT:** AP203 mixture (RESCOVIN®)
- **DIETARY_SUPPLEMENT:** AP203 mixture (RESCOVIN®)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06020001
- **Lead sponsor:** AronPharma Sp. z o. o.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-14
- **Primary completion:** 2023-04-27
- **Final completion:** 2023-04-27
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06020001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06020001, "Clinical Evaluation of the AP203 Plant Extract Mixture in Adult Patients With Increased Incidence of Viral and/or Bacterial Upper Respiratory Tract Infections". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06020001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*